<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00289133</url>
  </required_header>
  <id_info>
    <org_study_id>03111</org_study_id>
    <nct_id>NCT00289133</nct_id>
  </id_info>
  <brief_title>Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study</brief_title>
  <official_title>Prospective, Comparative, Randomized Study of GVF Versus Cross-linked Polyethylene in Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DePuy Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DePuy Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate long-term clinical and radiographic data between
      geometrically identical GVF and cross-linked polyethylene-bearing inserts in total knee
      arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In 1996, Gamma Vacuum Foil (GVF) polyethylene was introduced as the first polyethylene to be
      gamma irradiated and packaged in an inert environment. This polyethylene, with its patented
      process and packaging, continues to be the only barrier-packaged process that is impermeable
      to both Hydrogen (H2) and Oxygen (O2), and allows the polyethylene to recombine and
      cross-link in the package. Though the new moderately cross-linked polyethylene being
      evaluated in this protocol is comparable to GVF geometrically and mechanically, the P.F.C.®
      Sigma™ cross-linked polyethylene also has the added benefit of being completely oxidatively
      stable both on the shelf and in-vivo.

      The P.F.C. Sigma tibial tray component being assessed in this study is made of Cobalt Chrome
      (CoCr). The new CoCr tibial tray has the same design geometrically as the original titanium
      (Ti) tray, however, it features a highly polished top surface where it is joined to the
      polyethylene. This polished surface is designed to decrease the coefficient of friction
      between the polyethylene and the tray, thus minimizing backside wear. A comparative clinical
      study will be conducted to evaluate long-term clinical and radiographic data between
      geometrically identical cemented implants using GVF and crosslinked polyethylene tibial tray
      bearing inserts in Total Knee Arthroplasty (TKA) using the P.F.C. Sigma Total Knee System.
      Patients will be assigned to study treatment groups at random if they meet specific
      demographic and pathophysiologic criteria for cemented total knee arthroplasty. The
      anticipated duration of this investigation is a minimum six years, which includes a one-year
      enrollment phase.

      The specific aims of this study are as follows:

        1. Examine whether crosslinked polyethylene performs as well, if not better, than GVF
           polyethylene through standard clinical evaluations.

        2. Evaluate long-term survivorship rates.

        3. Report complications/adverse events.

        4. Report radiographic findings of geometrically identical implants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2005</start_date>
  <completion_date type="Actual">May 1, 2013</completion_date>
  <primary_completion_date type="Actual">May 1, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survivorship (Revision of Any Component for Any Reason)</measure>
    <time_frame>5 years</time_frame>
    <description>Survival was estimated by Kaplan-Meier method. Kaplan Meier survivorship analysis estimates the proportion of a population that will survive past a certain time avoiding a certain event. In this study, the event is removal of any component for any reason, also known as revision for any reason. Survival estimates are provided when 40 devices are left still being followed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Knee Society Evaluation - Total Score</measure>
    <time_frame>2 year</time_frame>
    <description>American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>American Knee Society Evaluation - Total Score</measure>
    <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
    <description>American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score</measure>
    <time_frame>2 year</time_frame>
    <description>WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score</measure>
    <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
    <description>WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (&gt;2mm)</measure>
    <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (&gt;2mm)</measure>
    <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Outcomes - Percentage of Knees With Femoral Osteolysis (&gt;2mm)</measure>
    <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Outcomes - Percentage of Knees With Tibial Osteolysis (&gt;2mm)</measure>
    <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">938</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Arthritis, Rheumatoid</condition>
  <arm_group>
    <arm_group_label>GVF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gamma Vacuum Foil polyethylene tibial insert</description>
  </arm_group>
  <arm_group>
    <arm_group_label>P.F.C.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cross-linked polyethylene tibial insert</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>total knee arthroplasty</intervention_name>
    <description>Gamma Vacuum Foil polyethylene tibial insert</description>
    <arm_group_label>GVF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>total knee arthroplasty</intervention_name>
    <description>cross-linked polyethylene tibial insert</description>
    <arm_group_label>P.F.C.</arm_group_label>
    <other_name>P.F.C. Sigma cross-linked bearing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Osteoarthritis of the affected joint appropriate for Total Knee Arthroplasty.

          2. Diagnosis of any of the following: rheumatoid or other inflammatory arthritis,
             post-traumatic arthritis, juvenile rheumatoid arthritis.

          3. Radiographic evidence of sufficient sound bone stock to seat and support the
             prosthesis.

          4. Subject requires a primary total knee replacement and is considered to be suitable for
             the specific knee prosthesis identified in protocol.

          5. Subject has given consent to the transfer of his/her information to sponsor.

          6. Subject will be compliant with requirements of protocol by returning for follow-up
             visits.

        Exclusion Criteria:

          1. History of recent/active joint sepsis.

          2. Charcot neuropathy.

          3. Psycho-social disorders that would limit rehabilitation.

          4. Women who are pregnant or planning on being pregnant.

          5. Greater than 80 years of age at the time of surgery.

          6. Prior ipsilateral knee arthroplasty.

          7. Metabolic disorders of calcified tissues, such as Paget's disease.

          8. Severe diabetes mellitus that is not controlled by diet or oral agents.

          9. Require joint replacement due to immunodeficiency syndromes.

         10. Skeletal immaturity.

         11. Avascular necrosis of the affected knee.

         12. Chronic renal disease.

         13. Subjects involved in medical-legal or worker's compensation claims.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gracia Etienne, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopaedic &amp; Spine Specialists</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael L. Granberry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alabama Orthopaedic Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard M. Konsens, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jewett Orthopaedic Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alabama Orthopaedic Clinic</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pacific Bone and Joint Clinic</name>
      <address>
        <city>Berkley</city>
        <state>California</state>
        <zip>94705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedic Center of the Rockies</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80525</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Ft. Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewett Orthopaedic Clinic</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jewett Orthopaedic Clinic</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rockford Orthopedic Associates</name>
      <address>
        <city>Rockford</city>
        <state>Illinois</state>
        <zip>61107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedic &amp; Spine Specialists</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17402</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2006</study_first_submitted>
  <study_first_submitted_qc>February 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2006</study_first_posted>
  <results_first_submitted>May 30, 2014</results_first_submitted>
  <results_first_submitted_qc>May 31, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 15, 2016</results_first_posted>
  <last_update_submitted>March 23, 2017</last_update_submitted>
  <last_update_submitted_qc>March 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty, Replacement, Knee</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>GVF Poly</title>
          <description>Gamma Vacuum Foil polyethylene tibial component</description>
        </group>
        <group group_id="P2">
          <title>XLK Poly</title>
          <description>Cross-linked polyethylene tibial component</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="461"/>
                <participants group_id="P2" count="477"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="189"/>
                <participants group_id="P2" count="179"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="272"/>
                <participants group_id="P2" count="298"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Non-study device implanted</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up - Hurricane Katri</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="41"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Revision</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="92"/>
                <participants group_id="P2" count="115"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Enrolled Subjects</population>
      <group_list>
        <group group_id="B1">
          <title>GVF Poly</title>
          <description>Gamma Vacuum Foil polyethylene tibial insert total knee arthroplasty: Gamma Vacuum Foil polyethylene tibial insert</description>
        </group>
        <group group_id="B2">
          <title>XLK Poly</title>
          <description>Cross-linked polyethylene tibial insert total knee arthroplasty: cross-linked polyethylene tibial insert</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="449"/>
            <count group_id="B2" value="477"/>
            <count group_id="B3" value="926"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.3" spread="8.5"/>
                    <measurement group_id="B2" value="66.4" spread="8.5"/>
                    <measurement group_id="B3" value="66.3" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="290"/>
                    <measurement group_id="B2" value="308"/>
                    <measurement group_id="B3" value="598"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="169"/>
                    <measurement group_id="B3" value="328"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="449"/>
                    <measurement group_id="B2" value="477"/>
                    <measurement group_id="B3" value="926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Survivorship (Revision of Any Component for Any Reason)</title>
        <description>Survival was estimated by Kaplan-Meier method. Kaplan Meier survivorship analysis estimates the proportion of a population that will survive past a certain time avoiding a certain event. In this study, the event is removal of any component for any reason, also known as revision for any reason. Survival estimates are provided when 40 devices are left still being followed.</description>
        <time_frame>5 years</time_frame>
        <population>Survivorship can only be calculated on knees (not participants as some study subjects had bilateral knees in the study) with post-operative follow-up. 35 knees were excluded due to post-operative follow-up not being available. 67 knees were excluded due to protocol violations.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene tibial insert total knee arthroplasty: Gamma Vacuum Foil polyethylene tibial insert</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene tibial insert total knee arthroplasty: cross-linked polyethylene tibial insert</description>
          </group>
        </group_list>
        <measure>
          <title>Survivorship (Revision of Any Component for Any Reason)</title>
          <description>Survival was estimated by Kaplan-Meier method. Kaplan Meier survivorship analysis estimates the proportion of a population that will survive past a certain time avoiding a certain event. In this study, the event is removal of any component for any reason, also known as revision for any reason. Survival estimates are provided when 40 devices are left still being followed.</description>
          <population>Survivorship can only be calculated on knees (not participants as some study subjects had bilateral knees in the study) with post-operative follow-up. 35 knees were excluded due to post-operative follow-up not being available. 67 knees were excluded due to protocol violations.</population>
          <units>percentage of knees</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>number of knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="337"/>
                <count group_id="O2" value="355"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>number of knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="402"/>
                <count group_id="O2" value="422"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.8" lower_limit="93.9" upper_limit="98.4"/>
                    <measurement group_id="O2" value="98.1" lower_limit="95.6" upper_limit="99.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>American Knee Society Evaluation - Total Score</title>
        <description>American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.</description>
        <time_frame>2 year</time_frame>
        <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>American Knee Society Evaluation - Total Score</title>
          <description>American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.</description>
          <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="240"/>
                <count group_id="O2" value="239"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="240"/>
                <count group_id="O2" value="239"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.7" spread="7.9"/>
                    <measurement group_id="O2" value="93.5" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>American Knee Society Evaluation - Total Score</title>
        <description>American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.</description>
        <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
        <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene tibial component</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene tibial component</description>
          </group>
        </group_list>
        <measure>
          <title>American Knee Society Evaluation - Total Score</title>
          <description>American Knee Society (AKS) knee score is a 0-100 point score (where 100 indicates excellent knee condition) that evaluates the affected knee. The knee score is composed of Pain, Range of Motion, and Stability.</description>
          <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="145"/>
                <count group_id="O2" value="146"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="145"/>
                <count group_id="O2" value="146"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" spread="9.2"/>
                    <measurement group_id="O2" value="93.1" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score</title>
        <description>WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.</description>
        <time_frame>2 year</time_frame>
        <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score</title>
          <description>WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.</description>
          <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>scores (points) on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="225"/>
                <count group_id="O2" value="221"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="225"/>
                <count group_id="O2" value="221"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="13.4"/>
                    <measurement group_id="O2" value="11.5" spread="15.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score</title>
        <description>WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.</description>
        <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
        <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Western Ontario and McMaster Universities Arthritis Index (WOMAC) Osteoarthritis Total Score</title>
          <description>WOMAC is a patient reported outcome (PRO) that evaluates the condition of subjects with knee osteoarthritis, and includes pain (score range 0-20), stiffness (score range 0-8), and physical function (score range 0-68) of the joint. The total score ranged from 0 to 96. The subscales are combined (summed) to compute a total score, where a lower score indicates a better outcome.</description>
          <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>scores (points) on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="134"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.0" spread="14.1"/>
                    <measurement group_id="O2" value="9.8" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (&gt;2mm)</title>
        <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
        <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Outcomes - Percentage of Knees With Femoral Radiolucencies (&gt;2mm)</title>
          <population>The number of knees analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>percentage of knees</units>
          <param>Number</param>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5"/>
                    <measurement group_id="O2" value="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (&gt;2mm)</title>
        <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
        <population>The number of knees in which the radiographs were analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Outcomes - Percentage of Knees With Tibial Radiolucencies (&gt;2mm)</title>
          <population>The number of knees in which the radiographs were analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>percentage of knees</units>
          <param>Number</param>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Outcomes - Percentage of Knees With Femoral Osteolysis (&gt;2mm)</title>
        <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
        <population>The number of knees in which radiographs were analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Outcomes - Percentage of Knees With Femoral Osteolysis (&gt;2mm)</title>
          <population>The number of knees in which radiographs were analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>percentage of knees</units>
          <param>Number</param>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Radiographic Outcomes - Percentage of Knees With Tibial Osteolysis (&gt;2mm)</title>
        <time_frame>Minimum 5 years, up to 7.6 years</time_frame>
        <population>The number of knees in which radiographs were analyzed was the number available for analysis at this post-operative timepoint.</population>
        <group_list>
          <group group_id="O1">
            <title>GVF Poly</title>
            <description>Gamma Vacuum Foil polyethylene</description>
          </group>
          <group group_id="O2">
            <title>XLK Poly</title>
            <description>Cross-linked polyethylene</description>
          </group>
        </group_list>
        <measure>
          <title>Radiographic Outcomes - Percentage of Knees With Tibial Osteolysis (&gt;2mm)</title>
          <population>The number of knees in which radiographs were analyzed was the number available for analysis at this post-operative timepoint.</population>
          <units>percentage of knees</units>
          <param>Number</param>
          <units_analyzed>Knees</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Knees</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
                <count group_id="O2" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0"/>
                    <measurement group_id="O2" value="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Intraoperatively and postoperatively through 6 years.</time_frame>
      <desc>Since study inception, information on whether an adverse event (AE) was deemed to be serious was not collected. AE terms that are consistent with the definition of Serious AEs are included in the Serious AE table. Remaining AEs (serious or not) are included in the &quot;Other&quot; AE table. MedDRA was used to classify each AE into SOC, not Preferred Term.</desc>
      <group_list>
        <group group_id="E1">
          <title>GVF Poly</title>
          <description>Gamma Vacuum Foil polyethylene tibial component</description>
        </group>
        <group group_id="E2">
          <title>XLK Poly</title>
          <description>Cross-linked polyethylene tibial component</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 16.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="461"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>Unknown Cause</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="461"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>Complications from Septic Shock due to Necrotic Gallbladder and Bowel</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Other - Had fall and fractured left shoulder and had a concussion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Other - Flexion Instability</sub_title>
                <description>Revision of right total knee</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Left Hip Revision</sub_title>
                <description>Underwent Total Hip Replacement after Breaking Hip</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Severe Low Back Pain</sub_title>
                <description>Led to Neurological Deficit</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Other - Death</sub_title>
                <description>Unknown Cause</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Ovarian Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Stage 4 Terminal Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Stage 4 Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Glioblastoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Central Nervous System</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Loosening</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Other - Death</sub_title>
                <description>From Respiratory Complications and Parkinson's Disease</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Other - Death</sub_title>
                <description>Reported Suicide</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Other - Follow-up Left Knee Arthroscope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Fall Injured Quad Repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA 16.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="146" subjects_at_risk="461"/>
                <counts group_id="E2" subjects_affected="164" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="461"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other-Syncope Weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Cardiac Arrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine/Metabolic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="461"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="17" subjects_affected="4" subjects_at_risk="461"/>
                <counts group_id="E2" events="14" subjects_affected="4" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Central Nervous System</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="19" subjects_affected="15" subjects_at_risk="461"/>
                <counts group_id="E2" events="34" subjects_affected="17" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Wound Problem</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="461"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Central Nervous System</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other-Positive Nasal Culture for MRSA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Wound Problem</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Hematological</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="461"/>
                <counts group_id="E2" events="9" subjects_affected="5" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Hematological</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Endocrine/Metabolic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Central Nervous System</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Endocrine/Metabolic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Extensor Mechanism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="68" subjects_affected="30" subjects_at_risk="461"/>
                <counts group_id="E2" events="87" subjects_affected="37" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Feeling of Instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other-Follow-up right knee arthroscope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Grade 1 Strain Medial Collateral Ligament</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other-Inflamed bursa over Gerdy's Tubercle</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other-Mild Limp Secondary to Stiffness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Patella Tendonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Patella Clunk</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Pes Bursitis; ITB syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Pesanserinus Tendonitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Pre Patellar Bursitis with Peri Patellar tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Routine F/U to Bilateral knee arthroscopic debulking</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- F/U Right Knee Arthroscope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>other- Right Ankle Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Subject has continuous right knee pain (non-surgical knee)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Synovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Stiffness, Arthrofibrosis, Ankylosis, Limited Range of Motion</sub_title>
                <counts group_id="E1" events="17" subjects_affected="12" subjects_at_risk="461"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Atraumatic onset of right buttock pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Hemarthrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - 20 degree flexion contracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Bilateral knee pain</sub_title>
                <description>Right knee pain greater than left knee pain; Arthroscope 2 months post-op</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Bilateral hand numbness and pain</sub_title>
                <description>Carpal Tunnel Syndrome</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Fell and injured quad</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Central Nervous System</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="461"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Peripheral Nervous System</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Advanced Alzheimer's</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Radiographic subsidence of the femoral component - asymptomatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Genitourinary</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="461"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory System</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Other- Dermis Contact Dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Itchy Red Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Psoriasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other- Skin Rash on Low Bilateral Legs</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Wound Problem</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Other- Change in Insurance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Systemic: Voluntary Withdrawal</sub_title>
                <description>Reason not specified; Surgical Site not specified</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="16" subjects_affected="10" subjects_at_risk="461"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Peri-op AE - Other</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="461"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Extensor Mechanism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Other - Left knee artrhoscopy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Thrombosis/Thrombophlebitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="461"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="477"/>
              </event>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="461"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="477"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Serious adverse events were not collected in this study per the modern definition. All adverse events collected for this study will be reported in the 'Other Adverse Events' table. MedDRA was used to classify each AE into SOC, but not Preferred Term.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Clinical Portfolio Leader</name_or_title>
      <organization>DePuy Orthopaedics, Inc.</organization>
      <phone>574-372-7231</phone>
      <email>shimden@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

